EXPRESSION OF ERYTHROID-SPECIFIC GENES IN ACUTE MEGAKARYOBLASTIC LEUKEMIA AND TRANSIENT MYELOPROLIFERATIVE DISORDER IN DOWNS-SYNDROME

被引:51
作者
ITO, E
KASAI, M
HAYASHI, Y
TOKI, T
ARAI, K
YOKOYAMA, S
KATO, K
TACHIBANA, N
YAMAMOTO, M
YOKOYAMA, M
机构
[1] UNIV TOKYO,FAC MED,DEPT PAEDIAT,TOKYO 113,JAPAN
[2] YAMAGATA UNIV,SCH MED,DEPT PAEDIAT,YAMAGATA 99023,JAPAN
[3] FIRST NAGOYA REDCROSS HOSP,DEPT PAEDIAT,NAGOYA,AICHI,JAPAN
[4] AOMORI PREFECTURAL CENT HOSP,DEPT PAEDIAT,AOMORI,JAPAN
[5] TOHOKU UNIV,SCH MED,DEPT BIOCHEM,SENDAI,MIYAGI 980,JAPAN
关键词
M7; TMD; GATA-1; GATA-2; GAMMA-GLOBIN;
D O I
10.1111/j.1365-2141.1995.tb05591.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute megakaryoblastic leukaemia (M7) and transient myeloproliferative disorder in Down's syndrome (TMD) are characterized by rapid growth of abnormal blast cells which express megakaryocytic markers. To clarify properties of the blast cells in M7 and TMD cases, we examined erythroid markers expression in blasts from six cases with M7 and seven cases with TMD in this study, Erythroid-specific mRNAs encoding gamma-globin and erythroid delta-aminolevulinate synthase were found to be expressed in blasts from most of these cases, indicating that majorities of the blasts in M7 and TMD cases have erythroid and megakaryocytic phenotypes. We also found that mRNAs encoding GATA-1 and GATA-2 are expressed in all these cases, These results suggest that M7 blasts and TMD blasts correspond to the erythroid/megakaryocytic bipotential progenitor cells.
引用
收藏
页码:607 / 614
页数:8
相关论文
共 40 条
  • [1] ERYTHROID TRANSCRIPTION FACTOR NF-E2 IS A HEMATOPOIETIC-SPECIFIC BASIC LEUCINE ZIPPER PROTEIN
    ANDREWS, NC
    ERDJUMENTBROMAGE, H
    DAVIDSON, MB
    TEMPST, P
    ORKIN, SH
    [J]. NATURE, 1993, 362 (6422) : 722 - 728
  • [2] CRITERIA FOR THE DIAGNOSIS OF ACUTE-LEUKEMIA OF MEGAKARYOCYTE LINEAGE (M7) - A REPORT OF THE FRENCH-AMERICAN-BRITISH COOPERATIVE GROUP
    BENNETT, JM
    CATOVSKY, D
    DANIEL, MT
    FLANDRIN, G
    GALTON, DAG
    GRALNICK, HR
    SULTAN, C
    [J]. ANNALS OF INTERNAL MEDICINE, 1985, 103 (03) : 460 - 462
  • [3] BENNETT JM, 1985, ANN INTERN MED, V103, P626
  • [4] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [5] MORPHOLOGICAL, IMMUNOLOGICAL AND CYTOGENETIC STUDIES IN ERYTHROLEUKEMIA - EVIDENCE FOR MULTILINEAGE INVOLVEMENT AND IDENTIFICATION OF 2 DISTINCT CYTOGENETIC-CLINICOPATHOLOGICAL TYPES
    CUNEO, A
    VANORSHOVEN, A
    MICHAUX, JL
    BOOGAERTS, M
    LOUWAGIE, A
    DOYEN, C
    DALCIN, P
    FAGIOLI, F
    CASTOLDI, G
    VANDENBERGHE, H
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (03) : 346 - 354
  • [6] 2 CHRONIC MYELOGENOUS LEUKEMIA-CELL LINES WHICH REPRESENT DIFFERENT STAGES OF ERYTHROID-DIFFERENTIATION
    ENDO, K
    HARIGAE, H
    NAGAI, T
    FUJIE, H
    MEGURO, K
    WATANABE, N
    FURUYAMA, K
    KAMEOKA, J
    OKUDA, M
    HAYASHI, N
    YAMAMOTO, M
    ABE, K
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1993, 85 (04) : 653 - 662
  • [7] A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY
    FEINBERG, AP
    VOGELSTEIN, B
    [J]. ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) : 6 - 13
  • [8] GREENBERG SM, 1988, BLOOD, V72, P1968
  • [9] THE T(4-11) CHROMOSOME-TRANSLOCATION OF HUMAN ACUTE LEUKEMIAS FUSES THE ALL-1 GENE, RELATED TO DROSOPHILA-TRITHORAX, TO THE AF-4 GENE
    GU, Y
    NAKAMURA, T
    ALDER, H
    PRASAD, R
    CANAANI, O
    CIMINO, G
    CROCE, CM
    CANAANI, E
    [J]. CELL, 1992, 71 (04) : 701 - 708
  • [10] HAYASHI Y, 1988, BLOOD, V72, P15